Published in J Neurol Neurosurg Psychiatry on August 01, 2009
An overview of human prion diseases. Virol J (2011) 1.08
Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report. BMC Neurol (2011) 0.75
Space Charge Regions in Fixed Charge Membranes and the Associated Property of Capacitance. Biophys J (1962) 7.78
Turnover of transmitter and synaptic vesicles at the frog neuromuscular junction. J Cell Biol (1973) 5.23
The ventral photoreceptor cells of Limulus. 3. A voltage-clamp study. J Gen Physiol (1969) 4.85
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
The ventral photoreceptor cells of Limulus. II. The basic photoresponse. J Gen Physiol (1969) 4.39
Neurotoxicity of a prion protein fragment. Nature (1993) 3.38
The ventral photoreceptor cells of Limulus. I. The microanatomy. J Gen Physiol (1969) 3.33
Equivalent Circuits as Related to Ionic Systems. Biophys J (1963) 3.08
Subthreshold behavior and phenomenological impedance of the squid giant axon. J Gen Physiol (1970) 3.02
Depletion of vesicles from frog neuromuscular junctions by prolonged tetanic stimulation. J Cell Biol (1972) 2.92
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett (1989) 2.69
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors. J Clin Oncol (2000) 2.60
Effects of black widow spider venom on the frog neuromuscular junction. Effects on end-plate potential, miniature end-plate potential and nerve terminal spike. Nature (1970) 2.42
Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem (2009) 2.34
Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology (1999) 2.33
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett (1988) 2.26
Properties of the major outer membrane protein from Neisseria gonorrhoeae incorporated into model lipid membranes. Proc Natl Acad Sci U S A (1983) 2.20
Changes in the fine structure of the neuromuscular junction of the frog caused by black widow spider venom. J Cell Biol (1972) 2.17
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol (1998) 2.15
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
Effects of calcium and magnesium on the frequency of miniature end-plate potentials during prolonged tetanization. J Physiol (1971) 1.96
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A (1996) 1.94
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol (2001) 1.94
Simple photoreceptors in Limulus polyphemus. Science (1966) 1.92
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology (2011) 1.91
Magnetic anisotropy and the orientation of retinal rods in a homogeneous magnetic field. Proc Natl Acad Sci U S A (1971) 1.88
Studies of Porins: Spontaneously Transferred from Whole Cells and Reconstituted from Purified Proteins of Neisseria gonorrhoeae and Neisseria meningitidis. Biophys J (1984) 1.79
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Purification from black widow spider venom of a protein factor causing the depletion of synaptic vesicles at neuromuscular junctions. J Cell Biol (1976) 1.72
Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem (2000) 1.71
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell (1994) 1.69
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Ann Oncol (2009) 1.68
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res (1997) 1.66
Prion protein amyloidosis. Brain Pathol (1996) 1.64
Effects of black widow spider venom on the frog neuromuscular junction. Effects on the fine structure of the frog neuromuscular junction. Nature (1970) 1.64
Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A (1990) 1.63
Evaluation of quinacrine treatment for prion diseases. J Virol (2003) 1.59
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology (2010) 1.59
Role for mouse macrophage IgG Fc receptor as ligand-dependent ion channel. Nature (1984) 1.58
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med (2009) 1.56
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol (2006) 1.54
Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest (1997) 1.54
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet (2000) 1.54
Spontaneous spongiform encephalopathy in a young adult rhesus monkey. Lancet (1996) 1.53
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol (1999) 1.49
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer. J Clin Oncol (1999) 1.43
p53 and chemosensitivity. Ann Oncol (1999) 1.42
Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann Oncol (2000) 1.40
A tentative interpretation of electromyographic regional differences in bulbar- and limb-onset ALS. Neurology (1999) 1.39
[Novel approaches; improved diagnostics and therapeutics with DNA microarrays. II. Applications]. Ned Tijdschr Geneeskd (2003) 1.39
Double mode of action of black widow spider venom on frog neuromuscular junction. J Neurocytol (1978) 1.36
Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett (1989) 1.35
Mitosis during postnatal growth in skeletal and cardiac muscle of the rat. J Anat (1968) 1.35
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res (1999) 1.31
Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. Clin Cancer Res (2001) 1.30
Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. J Neurol Sci (1985) 1.29
Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport (1993) 1.28
Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res (2000) 1.26
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre. J Clin Oncol (1997) 1.25
Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol (1995) 1.25
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy. Ann Oncol (2011) 1.24
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Ann Oncol (2011) 1.23
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer (1998) 1.23
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun (1993) 1.23
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol (1997) 1.22
Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology (1989) 1.22
Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil (2006) 1.22
Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett (2001) 1.21
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst (1995) 1.21
Human natural killer T cells acquire a memory-activated phenotype before birth. Blood (2000) 1.20
Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer (1999) 1.19
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors. Ann Oncol (2008) 1.17
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol (1996) 1.17
Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia (2012) 1.16
Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol (2001) 1.14
Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease. Nat Med (1995) 1.13
Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol (1995) 1.13
Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol (2000) 1.13